|
2025
|
G/S
|
Pharmaceutical preparations for the administration of hormones |
|
|
Invention
|
Kits for preparing and delivering purified corticotropin. A kit and sterile preparation of purifi... |
|
2024
|
Invention
|
Methods for storing and warming purified corticotropin compositions. A method of storing a steril... |
|
|
Invention
|
Methods for storing and warming purified corticotropin compositions. A method of warming a vial c... |
|
|
Invention
|
Stable oral baclofen compositions.
The present invention relates to stable liquid pharmaceutical... |
|
2023
|
Invention
|
Kits for preparing and delivering purified corticotropin. A sterile preparation of purified corti... |
|
|
Invention
|
Methods for storing and warming purified corticotropin compositions. A method of storing and warm... |
|
|
Invention
|
Stable oral suspensions of baclofen. The present invention relates to stable liquid pharmaceutica... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of oncological and cardiovascular diseases, hyperte... |
|
|
Invention
|
Liquid pharmaceutical compositions of baclofen for oral administration.
Liquid pharmaceutical co... |
|
2022
|
G/S
|
Medicinal hormone preparation containing zinc |
|
2020
|
Invention
|
Liquid pharmaceutical compositions of baclofen for oral administration. The present invention rel... |
|
2019
|
G/S
|
Medicinal hormone preparation |
|
2017
|
Invention
|
Medicament for the treatment of viral skin and tumour diseases. 3=independently H or OH, p=1 to 7... |
|
2016
|
Invention
|
Methods for treating female sexual dysfunction while decreasing cardiovascular risk.
Methods for... |
|
|
Invention
|
Commercial scale production methods for transdermal hormone formulations.
Methods for commercial... |
|
2015
|
G/S
|
Cardiovascular pharmaceuticals |
|
|
G/S
|
Cardiovascular agents for medical purposes; Cardiovascular pharmaceuticals; Cardiovascular treatm... |
|
2011
|
Invention
|
Methods for decreasing cardiovascular risk in postmenopausal women.
Methods for decreasing the r... |
|
|
Invention
|
Methods for treating sexual dysfunction while decreasing cardiovascular risk.
Methods for treati... |
|
2006
|
G/S
|
Pharmaceutical products for topical application, namely, pharmaceutical preparations for use in t... |
|
2004
|
G/S
|
Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use... |
|
|
G/S
|
SODIUM POLYSTYRENE SULFONATE FOR USE IN THE TREATMENT OF HYPERKLEMIA |
|
2002
|
Invention
|
Medicament for the treatment of viral skin and tumour diseases. 3=independent H or OH, p=1 to 7, ... |
|
|
G/S
|
pharmaceutical preparations for [ dermatolocial ] * dermatological * use, namely topical ointment... |
|
1995
|
Invention
|
Chimeric chains for receptor-associated signal transduction pathways. Chimeric proteins and DNA e... |
|
1994
|
G/S
|
adrenergic beta-receptor blocking agent for medical use |
|
1981
|
G/S
|
Cardiovascular Capsules |
|
1979
|
G/S
|
Psychopharmacological Agent |
|
1964
|
G/S
|
ADRENERGIC B-RECEPTOR BLOCKING AGENT FOR USE IN THE TREATMENT OF CERTAIN CARDIO-VASCULAR CONDITIONS |
|
1958
|
G/S
|
MEDICINAL ANTIBIOTIC PREPARATION |
